REMSIMA
REMSIMA
Dormant
DIN Number
02419483
Drug Class
Human
Market Date
Sep 18, 2014
Company
HC
Celltrion Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02419483
AIG Number0144162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AB02 INFLIXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
INFLIXIMABActive
Strength: 100 MG / VIAL
Monograph: INFLIXIMAB